Synergistic effects of AAGL and anti-PD-1 on hepatocellular carcinoma through lymphocyte recruitment to the liver

OBJECTIVE: Therapy for hepatocellular carcinoma (HCC) is a major challenge, and targeted therapies provide only a modest benefit in terms of overall survival. Treatment with antibodies to programmed cell death protein 1 (PD-1)/PD-L1 can restore the functions of tumor-infiltrating T cells in HCC and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Xiangdong, Wang, Xueqing, Yu, Wenhui, Yang, Qing, Li, Yan, Jin, Yanxia, Su, Yanting, Song, Jiaqi, Xu, Bo, Sun, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610148/
https://www.ncbi.nlm.nih.gov/pubmed/33710817
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8610148/
https://www.ncbi.nlm.nih.gov/pubmed/33710817
http://dx.doi.org/10.20892/j.issn.2095-3941.2020.0278

Ejemplares similares